BioChain Institute

A tissue microarray ( ) is an innovative technique that can be used to analyze multiple tissue samples simultaneously. This cost-effective method has been used across mediums in , research, proving its efficiency and versatility. Read more: https://bit.ly/3xDik8b

Multiomics and analyses have become critical methods in studying tumor samples. Considering the spatial proximity of within a tissue sample alongside differential expression analysis offers a more comprehensive picture of disease development, key driver mutations, and possible therapeutic targets. https://lnkd.in/gC2-4ibp

Spatial analysis sheds light on the possible role of ITLN2 expression in . For tissue expression analysis, RNA was obtained from BioChain Institute, Inc.

In this image you see colocalization of ITLN2NTERM and HD58C8 staining in Paneth cells in the ileum. The dotted blue line outlines the basolateral surface of identified Paneth cells, and the star indicates luminal orientation.

Scale bars: light microscopy 40× = 100 µm; fluorescence microscopy: 20× = 100 µm and 100× = 25 µm

Read publication - https://lnkd.in/g9EBx-ZD

BioChain Institute, Inc. recognizes Awareness month. Our aim is to support around the world achieve their goals. From the last 25 years our products and services have bolstered several projects.

The goal in now is to target care more precisely to patients through individualized health care. This is called , and it is an especially welcome change for cancer patients who traditionally have been exposed to treatment such as chemotherapy and radiation that attacks their cancer but often damages healthy tissue in the process.

In a study on mediated cancer immunotherapy by
Mary Litzinger – derived cDNAs, prepared from different individuals with different tumor types, were obtained from BioChain. American Association of Cancer Research

"Immunotherapeutic interventions against cancer depend on the identification of tumor antigens able to elicit a host immune response against the tumor cells" Read more: https://lnkd.in/ghuH3zdx

Are you a looking to learn of an exciting new use for formalin fixed, paraffin embedded (FFPE) tissue blocks and sections? If so, then you are in the right place. analyses such as next generation sequencing (NGS), PCR-based diagnostics, and microarray are all possible on nucleic acids extracted from this sample type.

Home BioChain provides high-quality solutions from biospecimen to analyzed results that accelerate innovation for precision medicine and diagnosis.

Did you know that your could influence your choice of partner? According to a study published in Genome biology https://lnkd.in/gpRR8hAd variation influences one’s choice of partner. The genetic correlation between height and the preference for a partner with similar height shows that genes affecting individual preferences for height and one’s own height are largely shared.

When our customers achieve desired research objectives, we at BioChain Institute, Inc. attains our goals too. We believe in making ! https://bit.ly/39XDMMC
Fulgent Genetics thank you for this great - we look forward to continuing to support your

In this study bit.ly/3wRWtcD - Human DNAJB6 cDNA was synthesized from total isolated from normal human adult heart from BioChain Institute, Inc. https://lnkd.in/gMeV_B-A

Phenotypic variation occurs in many inherited human diseases, and as a result, has made it difficult to identify specific mechanisms and potential therapeutics. Reasons for phenotypic variation are difficult to distinguish, as differences could result from combinatory interactions among several causative genes (Deacon et al., 2019; Gifford et al., 2019) or co-existence of a causative gene and a Disease Models & Mechanisms • DMM • Accepted manuscript modifier gene. Due to higher throughput than most other vertebrate models, zebrafish possess unique advantages for developing new methods that enable the discovery of modifying genes.

May is - BioChain Institute, Inc. honors Dr. Bernard Fisher.
Dr. Bernard Fisher's Research Left a Lasting Legacy of Improved Therapeutic Efficacy and Survival. Bernard Fisher, MD, is recognized today for his groundbreaking research in breast cancer, which ultimately ended the standard practice of performing the Halsted radical mastectomy, a treatment that had been in place for more than 75 years. His laboratory and clinical investigations led to more effective therapy, increased survival rates, and improved quality of life for women with breast cancer.